The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diagnostic Biomarkers Market Research Report 2025
Synopsis
The global Diagnostic Biomarkers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Biomarkers.
Report Scope
The Diagnostic Biomarkers market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen N.V.
Perkinelmer, Inc.
Merck Millipore
Bio-Rad Laboratories, Inc.
Enzo Biochem, Inc.
EKF Diagnostics Holdings, Inc.
Meso Scale Diagnostics, LLC.
Biosims Technologies Sas
Cisbio Bioassays
Signosis, Inc
Banyan Biomarkers, Inc
Biomedical Corp
Segment by Type
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
Segment by Application
Hospitals
Cancer Research Institutes
Diagnostic Labs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Biomarkers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Diagnostic Biomarkers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Biomarkers.
Report Scope
The Diagnostic Biomarkers market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen N.V.
Perkinelmer, Inc.
Merck Millipore
Bio-Rad Laboratories, Inc.
Enzo Biochem, Inc.
EKF Diagnostics Holdings, Inc.
Meso Scale Diagnostics, LLC.
Biosims Technologies Sas
Cisbio Bioassays
Signosis, Inc
Banyan Biomarkers, Inc
Biomedical Corp
Segment by Type
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
Segment by Application
Hospitals
Cancer Research Institutes
Diagnostic Labs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Biomarkers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Biomarkers Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Safety Biomarkers
1.2.3 Efficacy Biomarkers
1.2.4 Validation Biomarkers
1.3 Market by Application
1.3.1 Global Diagnostic Biomarkers Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Cancer Research Institutes
1.3.4 Diagnostic Labs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Biomarkers Market Perspective (2019-2030)
2.2 Diagnostic Biomarkers Growth Trends by Region
2.2.1 Global Diagnostic Biomarkers Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diagnostic Biomarkers Historic Market Size by Region (2019-2024)
2.2.3 Diagnostic Biomarkers Forecasted Market Size by Region (2025-2030)
2.3 Diagnostic Biomarkers Market Dynamics
2.3.1 Diagnostic Biomarkers Industry Trends
2.3.2 Diagnostic Biomarkers Market Drivers
2.3.3 Diagnostic Biomarkers Market Challenges
2.3.4 Diagnostic Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Biomarkers Players by Revenue
3.1.1 Global Top Diagnostic Biomarkers Players by Revenue (2019-2024)
3.1.2 Global Diagnostic Biomarkers Revenue Market Share by Players (2019-2024)
3.2 Global Diagnostic Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diagnostic Biomarkers Revenue
3.4 Global Diagnostic Biomarkers Market Concentration Ratio
3.4.1 Global Diagnostic Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Biomarkers Revenue in 2023
3.5 Diagnostic Biomarkers Key Players Head office and Area Served
3.6 Key Players Diagnostic Biomarkers Product Solution and Service
3.7 Date of Enter into Diagnostic Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Biomarkers Breakdown Data by Type
4.1 Global Diagnostic Biomarkers Historic Market Size by Type (2019-2024)
4.2 Global Diagnostic Biomarkers Forecasted Market Size by Type (2025-2030)
5 Diagnostic Biomarkers Breakdown Data by Application
5.1 Global Diagnostic Biomarkers Historic Market Size by Application (2019-2024)
5.2 Global Diagnostic Biomarkers Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diagnostic Biomarkers Market Size (2019-2030)
6.2 North America Diagnostic Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Diagnostic Biomarkers Market Size by Country (2019-2024)
6.4 North America Diagnostic Biomarkers Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diagnostic Biomarkers Market Size (2019-2030)
7.2 Europe Diagnostic Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Diagnostic Biomarkers Market Size by Country (2019-2024)
7.4 Europe Diagnostic Biomarkers Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Biomarkers Market Size (2019-2030)
8.2 Asia-Pacific Diagnostic Biomarkers Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Diagnostic Biomarkers Market Size by Region (2019-2024)
8.4 Asia-Pacific Diagnostic Biomarkers Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diagnostic Biomarkers Market Size (2019-2030)
9.2 Latin America Diagnostic Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Diagnostic Biomarkers Market Size by Country (2019-2024)
9.4 Latin America Diagnostic Biomarkers Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Biomarkers Market Size (2019-2030)
10.2 Middle East & Africa Diagnostic Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Diagnostic Biomarkers Market Size by Country (2019-2024)
10.4 Middle East & Africa Diagnostic Biomarkers Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Detail
11.1.2 Qiagen N.V. Business Overview
11.1.3 Qiagen N.V. Diagnostic Biomarkers Introduction
11.1.4 Qiagen N.V. Revenue in Diagnostic Biomarkers Business (2019-2024)
11.1.5 Qiagen N.V. Recent Development
11.2 Perkinelmer, Inc.
11.2.1 Perkinelmer, Inc. Company Detail
11.2.2 Perkinelmer, Inc. Business Overview
11.2.3 Perkinelmer, Inc. Diagnostic Biomarkers Introduction
11.2.4 Perkinelmer, Inc. Revenue in Diagnostic Biomarkers Business (2019-2024)
11.2.5 Perkinelmer, Inc. Recent Development
11.3 Merck Millipore
11.3.1 Merck Millipore Company Detail
11.3.2 Merck Millipore Business Overview
11.3.3 Merck Millipore Diagnostic Biomarkers Introduction
11.3.4 Merck Millipore Revenue in Diagnostic Biomarkers Business (2019-2024)
11.3.5 Merck Millipore Recent Development
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Bio-Rad Laboratories, Inc. Company Detail
11.4.2 Bio-Rad Laboratories, Inc. Business Overview
11.4.3 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Introduction
11.4.4 Bio-Rad Laboratories, Inc. Revenue in Diagnostic Biomarkers Business (2019-2024)
11.4.5 Bio-Rad Laboratories, Inc. Recent Development
11.5 Enzo Biochem, Inc.
11.5.1 Enzo Biochem, Inc. Company Detail
11.5.2 Enzo Biochem, Inc. Business Overview
11.5.3 Enzo Biochem, Inc. Diagnostic Biomarkers Introduction
11.5.4 Enzo Biochem, Inc. Revenue in Diagnostic Biomarkers Business (2019-2024)
11.5.5 Enzo Biochem, Inc. Recent Development
11.6 EKF Diagnostics Holdings, Inc.
11.6.1 EKF Diagnostics Holdings, Inc. Company Detail
11.6.2 EKF Diagnostics Holdings, Inc. Business Overview
11.6.3 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Introduction
11.6.4 EKF Diagnostics Holdings, Inc. Revenue in Diagnostic Biomarkers Business (2019-2024)
11.6.5 EKF Diagnostics Holdings, Inc. Recent Development
11.7 Meso Scale Diagnostics, LLC.
11.7.1 Meso Scale Diagnostics, LLC. Company Detail
11.7.2 Meso Scale Diagnostics, LLC. Business Overview
11.7.3 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Introduction
11.7.4 Meso Scale Diagnostics, LLC. Revenue in Diagnostic Biomarkers Business (2019-2024)
11.7.5 Meso Scale Diagnostics, LLC. Recent Development
11.8 Biosims Technologies Sas
11.8.1 Biosims Technologies Sas Company Detail
11.8.2 Biosims Technologies Sas Business Overview
11.8.3 Biosims Technologies Sas Diagnostic Biomarkers Introduction
11.8.4 Biosims Technologies Sas Revenue in Diagnostic Biomarkers Business (2019-2024)
11.8.5 Biosims Technologies Sas Recent Development
11.9 Cisbio Bioassays
11.9.1 Cisbio Bioassays Company Detail
11.9.2 Cisbio Bioassays Business Overview
11.9.3 Cisbio Bioassays Diagnostic Biomarkers Introduction
11.9.4 Cisbio Bioassays Revenue in Diagnostic Biomarkers Business (2019-2024)
11.9.5 Cisbio Bioassays Recent Development
11.10 Signosis, Inc
11.10.1 Signosis, Inc Company Detail
11.10.2 Signosis, Inc Business Overview
11.10.3 Signosis, Inc Diagnostic Biomarkers Introduction
11.10.4 Signosis, Inc Revenue in Diagnostic Biomarkers Business (2019-2024)
11.10.5 Signosis, Inc Recent Development
11.11 Banyan Biomarkers, Inc
11.11.1 Banyan Biomarkers, Inc Company Detail
11.11.2 Banyan Biomarkers, Inc Business Overview
11.11.3 Banyan Biomarkers, Inc Diagnostic Biomarkers Introduction
11.11.4 Banyan Biomarkers, Inc Revenue in Diagnostic Biomarkers Business (2019-2024)
11.11.5 Banyan Biomarkers, Inc Recent Development
11.12 Biomedical Corp
11.12.1 Biomedical Corp Company Detail
11.12.2 Biomedical Corp Business Overview
11.12.3 Biomedical Corp Diagnostic Biomarkers Introduction
11.12.4 Biomedical Corp Revenue in Diagnostic Biomarkers Business (2019-2024)
11.12.5 Biomedical Corp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
